National Research Corp (NRC) - Net Assets
Based on the latest financial reports, National Research Corp (NRC) has net assets worth $6.55 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($136.15 Million) and total liabilities ($129.60 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check NRC capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.55 Million |
| % of Total Assets | 4.81% |
| Annual Growth Rate | 12.88% |
| 5-Year Change | -83.61% |
| 10-Year Change | -83.11% |
| Growth Volatility | 154.22 |
National Research Corp - Net Assets Trend (1993–2025)
This chart illustrates how National Research Corp's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see how much is National Research Corp worth.
Annual Net Assets for National Research Corp (1993–2025)
The table below shows the annual net assets of National Research Corp from 1993 to 2025. Also explore NRC net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $13.99 Million | -55.28% |
| 2024-12-31 | $31.28 Million | -36.10% |
| 2023-12-31 | $48.95 Million | -32.04% |
| 2022-12-31 | $72.03 Million | -15.59% |
| 2021-12-31 | $85.34 Million | +32.69% |
| 2020-12-31 | $64.31 Million | +95.53% |
| 2019-12-31 | $32.89 Million | +72.36% |
| 2018-12-31 | $19.08 Million | -78.81% |
| 2017-12-31 | $90.04 Million | +8.74% |
| 2016-12-31 | $82.81 Million | +11.57% |
| 2015-12-31 | $74.22 Million | -15.41% |
| 2014-12-31 | $87.75 Million | +22.29% |
| 2013-12-31 | $71.75 Million | +26.46% |
| 2012-12-31 | $56.74 Million | +2.14% |
| 2011-12-31 | $55.55 Million | +14.35% |
| 2010-12-31 | $48.58 Million | +9.99% |
| 2009-12-31 | $44.17 Million | +14.44% |
| 2008-12-31 | $38.60 Million | -8.72% |
| 2007-12-31 | $42.29 Million | +15.06% |
| 2006-12-31 | $36.75 Million | +12.76% |
| 2005-12-31 | $32.59 Million | -6.92% |
| 2004-12-31 | $35.02 Million | +8.00% |
| 2003-12-31 | $32.42 Million | +15.72% |
| 2002-12-31 | $28.02 Million | +19.98% |
| 2001-12-31 | $23.35 Million | +9.22% |
| 2000-12-31 | $21.38 Million | +14.96% |
| 1999-12-31 | $18.60 Million | +6.90% |
| 1998-12-31 | $17.40 Million | -3.87% |
| 1997-12-31 | $18.10 Million | +761.90% |
| 1996-12-31 | $2.10 Million | +14.75% |
| 1995-12-31 | $1.83 Million | +12.75% |
| 1994-12-31 | $1.62 Million | +459.66% |
| 1993-12-31 | $290.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to National Research Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1729800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $32.00K | 0.23% |
| Other Components | $31.26 Million | 223.42% |
| Total Equity | $13.99 Million | 100.00% |
National Research Corp Competitors by Market Cap
The table below lists competitors of National Research Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MPS Limited
NSE:MPSLTD
|
$462.85 Million |
|
China Bicycle Co Holdings Ltd
SHE:000017
|
$463.15 Million |
|
GULF KEYSTONE PETR.
F:GVP1
|
$463.15 Million |
|
Titan International Inc
NYSE:TWI
|
$463.41 Million |
|
YeaShin International Development Co Ltd
TWO:5213
|
$462.70 Million |
|
Nextensa NV
BR:NEXTA
|
$462.51 Million |
|
Shengjing Bank Co. Ltd
F:6SY
|
$462.48 Million |
|
Digital Network S.A.
WAR:DIG
|
$462.43 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in National Research Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 31,284,000 to 13,990,000, a change of -17,294,000 (-55.3%).
- Net income of 11,600,000 contributed positively to equity growth.
- Dividend payments of 10,978,000 reduced retained earnings.
- Share repurchases of 20,180,000 reduced equity.
- Other factors increased equity by 2,264,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $11.60 Million | +82.92% |
| Dividends Paid | $10.98 Million | -78.47% |
| Share Repurchases | $20.18 Million | -144.25% |
| Other Changes | $2.26 Million | +16.18% |
| Total Change | $- | -55.28% |
Book Value vs Market Value Analysis
This analysis compares National Research Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 35.15x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 454.34x to 35.15x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1993-12-31 | $0.05 | $21.96 | x |
| 1994-12-31 | $0.27 | $21.96 | x |
| 1995-12-31 | $0.31 | $21.96 | x |
| 1996-12-31 | $0.34 | $21.96 | x |
| 1997-12-31 | $2.09 | $21.96 | x |
| 1998-12-31 | $2.09 | $21.96 | x |
| 1999-12-31 | $2.48 | $21.96 | x |
| 2000-12-31 | $3.03 | $21.96 | x |
| 2001-12-31 | $3.29 | $21.96 | x |
| 2002-12-31 | $3.91 | $21.96 | x |
| 2003-12-31 | $4.44 | $21.96 | x |
| 2004-12-31 | $4.81 | $21.96 | x |
| 2005-12-31 | $4.61 | $21.96 | x |
| 2006-12-31 | $5.31 | $21.96 | x |
| 2007-12-31 | $6.06 | $21.96 | x |
| 2008-12-31 | $5.65 | $21.96 | x |
| 2009-12-31 | $6.57 | $21.96 | x |
| 2010-12-31 | $7.21 | $21.96 | x |
| 2011-12-31 | $8.12 | $21.96 | x |
| 2012-12-31 | $8.16 | $21.96 | x |
| 2013-12-31 | $2.92 | $21.96 | x |
| 2014-12-31 | $3.57 | $21.96 | x |
| 2015-12-31 | $3.03 | $21.96 | x |
| 2016-12-31 | $3.37 | $21.96 | x |
| 2017-12-31 | $3.57 | $21.96 | x |
| 2018-12-31 | $0.68 | $21.96 | x |
| 2019-12-31 | $1.28 | $21.96 | x |
| 2020-12-31 | $2.50 | $21.96 | x |
| 2021-12-31 | $3.33 | $21.96 | x |
| 2022-12-31 | $2.88 | $21.96 | x |
| 2023-12-31 | $1.98 | $21.96 | x |
| 2024-12-31 | $1.32 | $21.96 | x |
| 2025-12-31 | $0.62 | $21.96 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently National Research Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 82.92%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.44%
- • Asset Turnover: 1.02x
- • Equity Multiplier: 9.64x
- Recent ROE (82.92%) is above the historical average (46.52%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1993 | 177.24% | 18.29% | 2.05x | 4.72x | $485.00K |
| 1994 | 97.97% | 23.54% | 1.91x | 2.18x | $1.43 Million |
| 1995 | 166.50% | 34.17% | 1.78x | 2.73x | $2.86 Million |
| 1996 | 109.52% | 18.25% | 2.03x | 2.95x | $2.09 Million |
| 1997 | 17.68% | 19.63% | 0.72x | 1.25x | $1.39 Million |
| 1998 | 2.87% | 2.82% | 0.67x | 1.51x | $-1.24 Million |
| 1999 | 8.06% | 8.24% | 0.62x | 1.58x | $-360.00K |
| 2000 | 12.71% | 14.83% | 0.58x | 1.48x | $578.48K |
| 2001 | 7.15% | 9.45% | 0.52x | 1.45x | $-665.02K |
| 2002 | 13.74% | 17.20% | 0.58x | 1.39x | $1.05 Million |
| 2003 | 13.52% | 16.28% | 0.59x | 1.41x | $1.14 Million |
| 2004 | 13.00% | 15.33% | 0.62x | 1.37x | $1.05 Million |
| 2005 | 16.06% | 16.14% | 0.73x | 1.37x | $1.98 Million |
| 2006 | 16.01% | 13.44% | 0.71x | 1.67x | $2.21 Million |
| 2007 | 16.17% | 13.98% | 0.79x | 1.46x | $2.61 Million |
| 2008 | 19.29% | 14.59% | 0.72x | 1.83x | $3.59 Million |
| 2009 | 19.22% | 14.72% | 0.80x | 1.64x | $4.07 Million |
| 2010 | 17.49% | 13.41% | 0.66x | 1.97x | $3.64 Million |
| 2011 | 20.82% | 15.26% | 0.75x | 1.81x | $6.01 Million |
| 2012 | 26.56% | 17.44% | 0.86x | 1.76x | $9.39 Million |
| 2013 | 21.58% | 16.72% | 0.83x | 1.55x | $8.31 Million |
| 2014 | 20.69% | 18.37% | 0.76x | 1.48x | $9.38 Million |
| 2015 | 23.73% | 17.21% | 0.79x | 1.74x | $10.19 Million |
| 2016 | 24.78% | 18.76% | 0.91x | 1.46x | $12.24 Million |
| 2017 | 25.48% | 19.52% | 0.92x | 1.41x | $13.94 Million |
| 2018 | 157.45% | 25.10% | 1.11x | 5.64x | $28.14 Million |
| 2019 | 98.52% | 25.32% | 1.16x | 3.37x | $29.12 Million |
| 2020 | 57.93% | 27.96% | 1.00x | 2.07x | $30.83 Million |
| 2021 | 43.90% | 25.32% | 0.94x | 1.85x | $28.93 Million |
| 2022 | 44.15% | 20.98% | 1.16x | 1.81x | $24.60 Million |
| 2023 | 63.26% | 20.84% | 1.21x | 2.50x | $26.08 Million |
| 2024 | 79.22% | 17.32% | 1.08x | 4.24x | $21.65 Million |
| 2025 | 82.92% | 8.44% | 1.02x | 9.64x | $10.20 Million |
Industry Comparison
This section compares National Research Corp's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $268,432,012
- Average return on equity (ROE) among peers: -224.26%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| National Research Corp (NRC) | $6.55 Million | 177.24% | 19.79x | $462.71 Million |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.53 Million |
| American Well Corp (AMWL) | $374.94 Million | -23.25% | 0.33x | $133.17 Million |
| Heartbeam Inc (BEAT) | $15.94 Million | -91.86% | 0.07x | $23.95 Million |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $-1.01 Million | 0.00% | 0.00x | $5.11 Million |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $784.08 Million | -6.88% | 5.94x | $10.63 Billion |
| Carlsmed, Inc. (CARL) | $98.87 Million | -29.97% | 0.32x | $409.27 Million |
| CareCloud, Inc. (CCLD) | $7.07 Million | -124.48% | 3.01x | $87.11 Million |
| Certara Inc (CERT) | $822.13 Million | -6.01% | 0.54x | $1.12 Billion |
| CareMax Inc (CMAX) | $505.37 Million | -1.32% | 0.29x | $381.50 |
| Claritev Corporation (CTEV) | $84.02 Million | -1958.81% | 60.30x | $555.59 Million |
About National Research Corp
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, an… Read more